share_log

Oracle | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lawrence Joseph Ellison(41.8%)

甲骨文 | SC 13G/A:超過5%持股股東披露文件(修正)-Lawrence Joseph Ellison(41.8%)

SEC announcement ·  02/10 05:36
牛牛AI助理已提取核心訊息
Oracle Corporation's co-founder, Lawrence Joseph Ellison, has filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, disclosing his beneficial ownership of Oracle shares. As of December 31, 2023, Ellison owns 1,152,982,353 shares of Oracle's common stock, which includes options to purchase an additional 7,250,000 shares exercisable within 60 days. This represents 41.8% of the company's class of securities. The filing, dated February 9, 2024, indicates that Ellison has sole voting and dispositive power over the shares, with no shared voting or dispositive power reported. The amendment, identified as No. 33, does not signify any change in Ellison's ownership status of more than five percent of Oracle's securities.
Oracle Corporation's co-founder, Lawrence Joseph Ellison, has filed an amended Schedule 13G/A with the United States Securities and Exchange Commission, disclosing his beneficial ownership of Oracle shares. As of December 31, 2023, Ellison owns 1,152,982,353 shares of Oracle's common stock, which includes options to purchase an additional 7,250,000 shares exercisable within 60 days. This represents 41.8% of the company's class of securities. The filing, dated February 9, 2024, indicates that Ellison has sole voting and dispositive power over the shares, with no shared voting or dispositive power reported. The amendment, identified as No. 33, does not signify any change in Ellison's ownership status of more than five percent of Oracle's securities.
甲骨文公司的聯合創始人勞倫斯·約瑟夫·埃裏森已向美國證券交易委員會提交了經修訂的附表13G/A,披露了他對甲骨文股票的實益所有權。截至2023年12月31日,埃裏森擁有甲骨文1,152,982,353股普通股,其中包括額外購買可在60天內行使的725萬股股票的期權。這佔公司證券類別的41.8%。這份日期爲2024年2月9日的文件表明,埃裏森對股票擁有唯一的投票權和處置權,沒有報告共享投票權或處置權。該修正案被確定爲第33號,並不表示埃裏森對甲骨文超過5%的證券的所有權狀況有任何變化。
甲骨文公司的聯合創始人勞倫斯·約瑟夫·埃裏森已向美國證券交易委員會提交了經修訂的附表13G/A,披露了他對甲骨文股票的實益所有權。截至2023年12月31日,埃裏森擁有甲骨文1,152,982,353股普通股,其中包括額外購買可在60天內行使的725萬股股票的期權。這佔公司證券類別的41.8%。這份日期爲2024年2月9日的文件表明,埃裏森對股票擁有唯一的投票權和處置權,沒有報告共享投票權或處置權。該修正案被確定爲第33號,並不表示埃裏森對甲骨文超過5%的證券的所有權狀況有任何變化。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。